Market Cap (In GBp)
1.18 Million
Revenue (In GBp)
543.25 Thousand
Net Income (In GBp)
-609.35 Thousand
Avg. Volume
4.34 Million
- Currency
- GBp
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.6-2.1
- PE
- -0.39
- EPS
- -0.01
- Beta Value
- 1.7
- ISIN
- GB00BDR6W943
- CUSIP
- G7097C113
- CIK
- -
- Shares
- 303209000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Peter Joseph Sargent
- Employee Count
- -
- Website
- https://www.physiomics.co.uk
- Ipo Date
- 2004-12-20
- Details
- Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union. It offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. The company also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxford, the United Kingdom.
More Stocks
-
EFXTEnerflex Ltd.
EFXT
-
KRYPFKerry Properties Limited
KRYPF
-
AMLI
-
AIZN
-
WWIB
-
3883
-
688665
-
NTAPNetApp, Inc.
NTAP